| Cardiovascular Function and Risk Factors | Lifetime | 41 | US 31 | 99.91 |
| Pulmonary Hypertension Research and Treatments | Lifetime | 22 | US 6 | 99.75 |
| Heart Failure Treatment and Management | Lifetime | 40 | US 26 | 99.83 |
| Cardiovascular and exercise physiology | Lifetime | 50 | US 27 | 99.63 |
| Diabetes Treatment and Management | Lifetime | 108 | US 47 | 99.50 |
| Cardiovascular Disease and Adiposity | Lifetime | 108 | US 68 | 99.35 |
| Cardiac Imaging and Diagnostics | Lifetime | 350 | US 189 | 99.42 |
| Congenital Heart Disease Studies | Lifetime | 236 | US 137 | 98.88 |
| Hemodynamic Monitoring and Therapy | Lifetime | 156 | US 56 | 98.73 |
| Cardiovascular Health and Disease Prevention | Lifetime | 184 | US 88 | 98.95 |
| Cardiac pacing and defibrillation studies | Lifetime | 226 | US 126 | 99.23 |
| Cardiac Valve Diseases and Treatments | Lifetime | 540 | US 278 | 98.92 |
| Cardiac Structural Anomalies and Repair | Lifetime | 814 | US 467 | 97.84 |
| Pericarditis and Cardiac Tamponade | Lifetime | 140 | US 67 | 96.20 |
| Mechanical Circulatory Support Devices | Lifetime | 891 | US 487 | 96.83 |
| Cardiovascular Effects of Exercise | Lifetime | 937 | US 404 | 95.45 |
| Cardiovascular Function and Risk Factors | 2021-2025 | 4 | US 3 | 99.97 |
| Cardiovascular Disease and Adiposity | 2021-2025 | 5 | US 3 | 99.50 |
| Pulmonary Hypertension Research and Treatments | 2021-2025 | 5 | US 1 | 99.72 |
| Heart Failure Treatment and Management | 2021-2025 | 9 | US 6 | 99.90 |
| Cardiovascular and exercise physiology | 2021-2025 | 7 | US 2 | 99.54 |
| Diabetes Treatment and Management | 2021-2025 | 20 | US 12 | 99.81 |
| Congenital Heart Disease Studies | 2021-2025 | 26 | US 14 | 98.66 |
| Cardiac pacing and defibrillation studies | 2021-2025 | 64 | US 27 | 99.08 |
| Hemodynamic Monitoring and Therapy | 2021-2025 | 49 | US 13 | 97.62 |
| Cardiac Valve Diseases and Treatments | 2021-2025 | 208 | US 92 | 98.59 |
| Cardiac Arrhythmias and Treatments | 2021-2025 | 380 | US 103 | 96.98 |
| Cardiac Imaging and Diagnostics | 2021-2025 | 583 | US 171 | 96.27 |
| Atrial Fibrillation Management and Outcomes | 2021-2025 | 594 | US 154 | 95.93 |
| Pancreatic function and diabetes | 2021-2025 | 716 | US 247 | 89.64 |
| Cardiovascular Issues in Pregnancy | 2021-2025 | 411 | US 165 | 85.19 |
| Cardiovascular Health and Disease Prevention | 2021-2025 | 791 | US 202 | 83.49 |
| Cardiovascular Effects of Exercise | 2021-2025 | 817 | US 219 | 83.70 |
| Pericarditis and Cardiac Tamponade | 2021-2025 | 146 | US 49 | 79.47 |
| GDF15 and Related Biomarkers | 2021-2025 | 326 | US 89 | 66.94 |
